Literature DB >> 24145895

Effects of opium consumption on cardiometabolic diseases.

Farzad Masoudkabir1, Nizal Sarrafzadegan, Mark J Eisenberg.   

Abstract

Opium is the second-most-commonly abused substance (after tobacco) in developing countries of the Middle East region, and in many Asian nations. One of the reasons for the high prevalence of opium abuse in these countries is a traditional belief among Eastern people, even including some medical staff, that opium might have beneficial effects on cardiovascular health and in the control of diabetes mellitus, hypertension, and dyslipidaemia. In this Perspectives article, we summarize the current understanding of the pharmacotoxicology of opium and its specific effects on glycaemic control, blood pressure, lipid profile, and atherosclerosis. On the basis of the available evidence, we believe not only that opium has no ameliorating effect on cardiovascular diseases, but also that the use of this drug might have adverse effects on these conditions. Therefore, people should be educated about the hazardous effects of opium consumption on cardiometabolic diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24145895     DOI: 10.1038/nrcardio.2013.159

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  63 in total

1.  Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution.

Authors:  C N May; M R Dashwood; C J Whitehead; C J Mathias
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

2.  Opium decreases the age at myocardial infarction and sudden cardiac death: a long- and short-term outcome evaluation.

Authors:  Hamidreza Roohafza; Mohammad Talaei; Masoumeh Sadeghi; Poone Haghani; Pedram Shokouh; Nizal Sarrafzadegan
Journal:  Arch Iran Med       Date:  2013-03       Impact factor: 1.354

Review 3.  Endogenous sex steroids and cardio- and cerebro-vascular disease in the postmenopausal period.

Authors:  Theodora Pappa; Maria Alevizaki
Journal:  Eur J Endocrinol       Date:  2012-05-18       Impact factor: 6.664

Review 4.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

5.  Coronary artery disease and opioid use.

Authors:  Michael Marmor; Arthur Penn; Kyle Widmer; Richard I Levin; Robert Maslansky
Journal:  Am J Cardiol       Date:  2004-05-15       Impact factor: 2.778

6.  The association of opium with coronary artery disease.

Authors:  Saeed Sadeghian; Soodabeh Darvish; Gholamreza Davoodi; Mojtaba Salarifar; Mehran Mahmoodian; Nader Fallah; Abbas Ali Karimi
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-10

7.  Opiates increase plasma catecholamines in humans.

Authors:  M Hoehe; T Duka
Journal:  Psychoneuroendocrinology       Date:  1993       Impact factor: 4.905

Review 8.  Healthy hearts--and the universal benefits of being physically active: physical activity and health.

Authors:  Steven N Blair; Jeremy N Morris
Journal:  Ann Epidemiol       Date:  2009-04       Impact factor: 3.797

9.  Prediction of coronary atherosclerotic disease with liver transaminase level.

Authors:  Peyman Adibi; Masoumeh Sadeghi; Majid Mahsa; Golnaz Rozati; Masood Mohseni
Journal:  Liver Int       Date:  2007-09       Impact factor: 5.828

10.  Opium can differently alter blood glucose, sodium and potassium in male and female rats.

Authors:  Gholamreza Asadi Karam; Hamid Reza Rashidinejad; Mohammad Mehdi Aghaee; Jafar Ahmadi; Mohammad Reza Rahmani; Mehdi Mahmoodi; Hosein Azin; Mohammad Reza Mirzaee; Mohammad Khaksari
Journal:  Pak J Pharm Sci       Date:  2008-04       Impact factor: 0.684

View more
  23 in total

1.  Adverse cardiac events associated with incident opioid drug use among older adults with COPD.

Authors:  Nicholas T Vozoris; Xuesong Wang; Peter C Austin; Douglas S Lee; Anne L Stephenson; Denis E O'Donnell; Sudeep S Gill; Paula A Rochon
Journal:  Eur J Clin Pharmacol       Date:  2017-06-29       Impact factor: 2.953

2.  Opium Addiction and Correlation with Early and Six-month Outcomes of Presenting with ST Elevation Myocardial Infarction Treated Initially with Thrombolytic Therapy.

Authors:  Mehdi Mousavi; Solmaz Kalhor; Mahlaa Alizadeh; Mohamad Reza Movahed
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

3.  Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study.

Authors:  Mahdi Nalini; Masoud Khoshnia; Farin Kamangar; Maryam Sharafkhah; Hossein Poustchi; Akram Pourshams; Gholamreza Roshandel; Samad Gharavi; Mahdi Zahedi; Alireza Norouzi; Masoud Sotoudeh; Arash Nikmanesh; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh; Arash Etemadi
Journal:  Int J Epidemiol       Date:  2021-03-03       Impact factor: 7.196

4.  THE EFFECTS OF OPIUM ADDICTION ON THYROID AND SEX HORMONES IN DIABETIC AND NON-DIABETIC MALE AND FEMALE RATS.

Authors:  G Asadikaram; H Akbari; S Vakili; M Asiabanha; N Shahrokhi; A Savardashtaki
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Oct-Dec       Impact factor: 0.877

5.  Mortality from respiratory diseases associated with opium use: a population-based cohort study.

Authors:  Atieh Rahmati; Ramin Shakeri; Hooman Khademi; Hossein Poutschi; Akram Pourshams; Arash Etemadi; Masoud Khoshnia; Amir Ali Sohrabpour; Ali Aliasgari; Elham Jafari; Farhad Islami; Shahryar Semnani; Abdolsamad Gharravi; Christian C Abnet; Paul D P Pharoah; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Reza Malekzadeh; Farin Kamangar
Journal:  Thorax       Date:  2016-11-24       Impact factor: 9.139

6.  Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study.

Authors:  Mahdi Nalini; Ramin Shakeri; Hossein Poustchi; Akram Pourshams; Arash Etemadi; Farhad Islami; Masoud Khoshnia; Abdolsamad Gharavi; Gholamreza Roshandel; Hooman Khademi; Mahdi Zahedi; Behnoush Abedi-Ardekani; Rajesh Vedanthan; Paolo Boffetta; Sanford M Dawsey; Paul D Pharaoh; Masoud Sotoudeh; Christian C Abnet; Nicholas E Day; Paul Brennan; Farin Kamangar; Reza Malekzadeh
Journal:  Eur J Prev Cardiol       Date:  2021-03-23       Impact factor: 7.804

Review 7.  The Impact of Opium Consumption on Blood Glucose, Serum Lipids and Blood Pressure, and Related Mechanisms.

Authors:  Hamid Najafipour; Ahmad Beik
Journal:  Front Physiol       Date:  2016-10-13       Impact factor: 4.566

8.  Investigating Changes in Serum Biochemical Parameters in Opium Addicts Before and During Addiction Treatment.

Authors:  Sedigheh Barzehkar; Mohammad Hossein Gozashti; Kouros Divsalar; Mahdieh Mashrouteh; Amir Hossein Darvishi-Lardi
Journal:  Addict Health       Date:  2016

9.  Opium use reporting error in case-control studies: neighborhood controls versus hospital visitor controls.

Authors:  Elham Mohebbi; Hamideh Rashidian; Ahmad Naghibzadeh Tahami; Ali Akbar Haghdoost; Afarin Rahimi-Movaghar; Monireh Sadat Seyyedsalehi; Abass Rezaianzadeh; Maryam Marzban; Abdolvahab Moradi; Mahin Gholipour; Maryam Hadji; Farin Kamangar; Kazem Zendehdel
Journal:  Med J Islam Repub Iran       Date:  2021-05-10

10.  Outcomes and long-term survival of coronary artery surgery: The controversial role of opium as risk marker.

Authors:  Mahdi Najafi; Leila Jahangiry; Seyedeh Hamideh Mortazavi; Arash Jalali; Abbasali Karimi; Ali Bozorgi
Journal:  World J Cardiol       Date:  2016-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.